Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams

Alexander J. Bondoc, Mubeen Jafri, Bryan Donnelly, Sujit K. Mohanty, Monica M. McNeal, Richard L. Ward, Greg M. Tiao

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: Biliary atresia (BA) is a neonatal disease that results in the obliteration of the biliary tree. The murine model of BA has been established where rhesus rotavirus (RRV) infection of newborn mice leads to an obstructive cholangiopathy. We determined whether maternal postconception rotavirus vaccination could prevent the murine model of BA. Materials and Methods: Female mice were mated and injected intraperitoneally with one of the following materials: purified rotavirus strains RRV or Wa, high or low-dose Rotateq (Merck and Co Inc, Whitehouse Station, NJ) (a pentavalent rotavirus vaccine [PRV]), purified recombinant viral antigens of rotavirus (VP6) or influenza (NP), or saline. B-cell-deficient females also underwent postconception PRV injection. Results: Maternal vaccination with PRV improves survival of pups infected with RRV. Serum rotavirus IgG, but not IgA, levels were increased in pups delivered from dams who received RRV, Wa, PRV, or VP6, but in the case of the Wa, PRV, and VP6 groups, these antibodies were not neutralizing. Postconception injection of high-dose PRV did not improve survival of pups born to B-cell-deficient dams. Conclusion: Maternal vaccination against RRV can prevent the rotavirus-induced murine model of BA in newborn mouse pups.

Original languageEnglish (US)
Pages (from-to)1479-1490
Number of pages12
JournalJournal of Pediatric Surgery
Volume44
Issue number8
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Biliary Atresia
Rotavirus
Rotavirus Vaccines
Vaccination
Mothers
Infant, Newborn, Diseases
B-Lymphocytes
Rotavirus Infections
Injections
Viral Antigens
Biliary Tract
Immunoglobulin A
Human Influenza
Immunoglobulin G

Keywords

  • Biliary atresia
  • Maternal immunization
  • Rotateq
  • Rotavirus

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Bondoc, A. J., Jafri, M., Donnelly, B., Mohanty, S. K., McNeal, M. M., Ward, R. L., & Tiao, G. M. (2009). Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. Journal of Pediatric Surgery, 44(8), 1479-1490. https://doi.org/10.1016/j.jpedsurg.2009.05.034

Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. / Bondoc, Alexander J.; Jafri, Mubeen; Donnelly, Bryan; Mohanty, Sujit K.; McNeal, Monica M.; Ward, Richard L.; Tiao, Greg M.

In: Journal of Pediatric Surgery, Vol. 44, No. 8, 08.2009, p. 1479-1490.

Research output: Contribution to journalArticle

Bondoc, Alexander J. ; Jafri, Mubeen ; Donnelly, Bryan ; Mohanty, Sujit K. ; McNeal, Monica M. ; Ward, Richard L. ; Tiao, Greg M. / Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. In: Journal of Pediatric Surgery. 2009 ; Vol. 44, No. 8. pp. 1479-1490.
@article{26435e944ef04a56814c2d68a6d03b21,
title = "Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams",
abstract = "Purpose: Biliary atresia (BA) is a neonatal disease that results in the obliteration of the biliary tree. The murine model of BA has been established where rhesus rotavirus (RRV) infection of newborn mice leads to an obstructive cholangiopathy. We determined whether maternal postconception rotavirus vaccination could prevent the murine model of BA. Materials and Methods: Female mice were mated and injected intraperitoneally with one of the following materials: purified rotavirus strains RRV or Wa, high or low-dose Rotateq (Merck and Co Inc, Whitehouse Station, NJ) (a pentavalent rotavirus vaccine [PRV]), purified recombinant viral antigens of rotavirus (VP6) or influenza (NP), or saline. B-cell-deficient females also underwent postconception PRV injection. Results: Maternal vaccination with PRV improves survival of pups infected with RRV. Serum rotavirus IgG, but not IgA, levels were increased in pups delivered from dams who received RRV, Wa, PRV, or VP6, but in the case of the Wa, PRV, and VP6 groups, these antibodies were not neutralizing. Postconception injection of high-dose PRV did not improve survival of pups born to B-cell-deficient dams. Conclusion: Maternal vaccination against RRV can prevent the rotavirus-induced murine model of BA in newborn mouse pups.",
keywords = "Biliary atresia, Maternal immunization, Rotateq, Rotavirus",
author = "Bondoc, {Alexander J.} and Mubeen Jafri and Bryan Donnelly and Mohanty, {Sujit K.} and McNeal, {Monica M.} and Ward, {Richard L.} and Tiao, {Greg M.}",
year = "2009",
month = "8",
doi = "10.1016/j.jpedsurg.2009.05.034",
language = "English (US)",
volume = "44",
pages = "1479--1490",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams

AU - Bondoc, Alexander J.

AU - Jafri, Mubeen

AU - Donnelly, Bryan

AU - Mohanty, Sujit K.

AU - McNeal, Monica M.

AU - Ward, Richard L.

AU - Tiao, Greg M.

PY - 2009/8

Y1 - 2009/8

N2 - Purpose: Biliary atresia (BA) is a neonatal disease that results in the obliteration of the biliary tree. The murine model of BA has been established where rhesus rotavirus (RRV) infection of newborn mice leads to an obstructive cholangiopathy. We determined whether maternal postconception rotavirus vaccination could prevent the murine model of BA. Materials and Methods: Female mice were mated and injected intraperitoneally with one of the following materials: purified rotavirus strains RRV or Wa, high or low-dose Rotateq (Merck and Co Inc, Whitehouse Station, NJ) (a pentavalent rotavirus vaccine [PRV]), purified recombinant viral antigens of rotavirus (VP6) or influenza (NP), or saline. B-cell-deficient females also underwent postconception PRV injection. Results: Maternal vaccination with PRV improves survival of pups infected with RRV. Serum rotavirus IgG, but not IgA, levels were increased in pups delivered from dams who received RRV, Wa, PRV, or VP6, but in the case of the Wa, PRV, and VP6 groups, these antibodies were not neutralizing. Postconception injection of high-dose PRV did not improve survival of pups born to B-cell-deficient dams. Conclusion: Maternal vaccination against RRV can prevent the rotavirus-induced murine model of BA in newborn mouse pups.

AB - Purpose: Biliary atresia (BA) is a neonatal disease that results in the obliteration of the biliary tree. The murine model of BA has been established where rhesus rotavirus (RRV) infection of newborn mice leads to an obstructive cholangiopathy. We determined whether maternal postconception rotavirus vaccination could prevent the murine model of BA. Materials and Methods: Female mice were mated and injected intraperitoneally with one of the following materials: purified rotavirus strains RRV or Wa, high or low-dose Rotateq (Merck and Co Inc, Whitehouse Station, NJ) (a pentavalent rotavirus vaccine [PRV]), purified recombinant viral antigens of rotavirus (VP6) or influenza (NP), or saline. B-cell-deficient females also underwent postconception PRV injection. Results: Maternal vaccination with PRV improves survival of pups infected with RRV. Serum rotavirus IgG, but not IgA, levels were increased in pups delivered from dams who received RRV, Wa, PRV, or VP6, but in the case of the Wa, PRV, and VP6 groups, these antibodies were not neutralizing. Postconception injection of high-dose PRV did not improve survival of pups born to B-cell-deficient dams. Conclusion: Maternal vaccination against RRV can prevent the rotavirus-induced murine model of BA in newborn mouse pups.

KW - Biliary atresia

KW - Maternal immunization

KW - Rotateq

KW - Rotavirus

UR - http://www.scopus.com/inward/record.url?scp=67650935178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650935178&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2009.05.034

DO - 10.1016/j.jpedsurg.2009.05.034

M3 - Article

C2 - 19635292

AN - SCOPUS:67650935178

VL - 44

SP - 1479

EP - 1490

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 8

ER -